Exicure Inc (XCUR): XCUR...$10.40...🥳...Scaling in a...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	2370
Posts	117859
Boards Moderated	0
Alias Born	12/17/2011

georgie18

Re: None

Thursday, 04/17/2025 5:20:34 PM

Thursday, April 17, 2025 5:20:34 PM

XCUR...$10.40...🥳...Scaling in and bidding $8 range...Ran from $2 range to $27 on my previous alert...Although I was all out in the $15/$16 range...

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent XCUR News

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100) • GlobeNewswire Inc. • 04/22/2026 11:54:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:15:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:15:02 PM
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions • GlobeNewswire Inc. • 04/02/2026 08:01:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:40:30 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:42:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:32:21 PM
Exicure, Inc. Reports Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/25/2026 08:18:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:25:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 09:25:41 PM
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant • GlobeNewswire Inc. • 02/05/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:29:08 PM
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/21/2026 06:21:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 05:46:19 PM
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings • GlobeNewswire Inc. • 01/21/2026 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2026 07:09:18 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 01:42:41 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2025 01:51:19 AM
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting • GlobeNewswire Inc. • 12/08/2025 09:30:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 04:50:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 09:52:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 09:17:16 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent XCUR News

More XCUR News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent XCUR News

Go Ad-Free